NFL legend Tom Brady publicly praised billionaire doctor Patrick Soon-Shiong for his work on cancer treatment, commenting on a post from NewsNation announcing an upcoming interview about a supposed cancer breakthrough.
The 48-year-old former quarterback responded on November 17, 2025, to a NewsNation preview of an interview between Chris Cuomo and Soon-Shiong, the billionaire owner of the Los Angeles Times. Brady thanked Soon-Shiong for his “incredible work” and emphasized that more minds like this are needed to attack the world’s biggest problems.
The interview, which aired Tuesday, Nov. 25, featured Soon-Shiong discussing what he claims the federal government dismisses as a treatment breakthrough. In the preview clip, Soon-Shiong suggested that federal authorities are aware of his work but do not prioritize what he considers crucial cancer research.
Soon-Shiong has a lengthy history of developing cancer treatments. In 1995, he invented Abraxane, a chemotherapy drug that treats pancreatic, breast, and lung cancers. The medication has received FDA approval and is used for advanced pancreatic and breast cancers, as well as non-small cell lung cancer.
The billionaire physician has maintained close ties to Donald Trump’s political circle. During Trump’s first term, Soon-Shiong sought to serve as Trump’s health care czar. More recently, Brady and Trump shared a suite at a FIFA match, demonstrating the quarterback’s ongoing connection to the former president.
Brady’s relationship with Trump dates back years. In 2015, Brady called Trump a good friend during an interview. However, speaking with Variety in 2022, the quarterback said his relationship with Trump was mischaracterized by the media.
Soon-Shiong purchased the Los Angeles Times in 2018, bringing the newspaper under his ownership. His tenure has been marked by controversial editorial decisions that reflect his political leanings. Most notably, Soon-Shiong vetoed the editorial board’s planned endorsement of Kamala Harris during the presidential race.
The newspaper owner has worked to reshape the Times’ opinion pages to appeal to more conservative readers. He added Scott Jennings, a conservative commentator, to the editorial board. Soon-Shiong has also explored business ventures with right-wing media personalities, including discussions with Candace Owens for a separate media project distinct from the newspaper.
Brady’s public support for Soon-Shiong’s medical work comes as the physician positions himself as both a medical innovator and a Trump ally. The multihyphenate Soon-Shiong combines roles as a medical doctor, researcher, investor, and newspaper owner, making him a unique figure in both healthcare and media circles.
Brady expressed enthusiasm about watching the NewsNation interview, highlighting his belief that more attention should be directed toward innovative approaches to major health challenges. His comments amplified Soon-Shiong’s message ahead of the broadcast, potentially drawing significant viewership to the program.
Brady’s evolving relationship with Trump has attracted media scrutiny throughout his career. During Trump’s initial presidential campaign, Brady was seen as an informal endorser after a “Make America Great Again” hat appeared in his locker, which he called “a nice keepsake” at the time.
The quarterback later attempted to distance himself from political associations, telling Variety that he had not spoken with Trump in years by 2022. Brady expressed frustration with how the media portrayed his political views, stating he would not respond to every characterization made about his beliefs.
Soon-Shiong’s interview promised to reveal details about cancer treatment approaches he believes deserve greater attention from federal health authorities. The physician’s claims of governmental dismissal of his work set the stage for what NewsNation is promoting as a significant medical disclosure.
The intersection of sports celebrity, political connections, and medical innovation creates an unusual alliance between Brady and Soon-Shiong. Brady’s endorsement carries substantial weight given his status as one of the most successful athletes in NFL history. His willingness to publicly support Soon-Shiong’s work provides the physician with a powerful platform to reach audiences who might not otherwise engage with medical research discussions.